Clinical Trial Update: Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy volunteers and patients with atopic dermatitis and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Pruritus

Drugs mentioned

• ATTO-1310

Snippet

Sponsor: Attovia Therapeutics Inc | Conditions: Normal Volunteers, Atopic Dermatitis (AD) | Phase 1 | Status: ACTIVE_NOT_RECRUITING